Giri Suprabhat, Choudhury Ashok, Praharaj Dibya L, Singh Ankita, Vaidya Arun, Harindranath Sidharth, Anirvan Prajna, Kalia Shivam, Shukla Akash
Department of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Bhubaneswar, India.
Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101391. doi: 10.1016/j.jceh.2024.101391. Epub 2024 Mar 4.
Recent studies from both India and outside India have shown a change in the etiological profile of hepatocellular carcinoma (HCC). We aimed to analyze the etiological spectrum and changing trends of HCC etiology in India using a systematic review of current literature and meta-analysis.
Electronic databases of PubMed/Medline, Scopus, and Embase were searched from inception to July 2023 for studies reporting the data on the etiology of HCC from India. The pooled proportions with 95% confidence interval were calculated using summative statistics.
A total of 60 studies (n = 12,327) were included in the final analysis. The pooled proportions of HCC cases with at least one positive and negative viral marker were 56.0 (49.5-62.6) and 43.1% (36.5-49.8), respectively. The pooled proportion of HCC cases with positive hepatitis B virus (HBV) markers was 41.0 (35.8-46.1), while those with positive markers for hepatitis C virus were 20.3 (17.0-23.6). The pooled proportion of cases with HCC with significant alcohol intake was 19.0% (15.6-22.4), and those related to nonalcoholic fatty liver disease (NAFLD) were 16.9% (12.1-21.7). Around 7.9% (5.8-10.0) of the cases had HCC with multiple etiologies. Subgroup analysis showed a significant variation with the location of the study based on zone. Meta-regression analysis based on publication year (1990-2023) showed a significant reduction in the proportion of cases with HBV and an increase in cases with NAFLD. In contrast, the proportion of cases with hepatitis C virus and alcohol did not change significantly.
Viral hepatitis is the most common etiology of HCC in India, predominantly HBV. The proportions of cases with HCC related to NAFLD are increasing, and those related to HBV are declining.
印度国内外最近的研究表明肝细胞癌(HCC)的病因学特征发生了变化。我们旨在通过对当前文献的系统综述和荟萃分析,分析印度HCC病因的频谱及其变化趋势。
检索PubMed/Medline、Scopus和Embase电子数据库,从建库至2023年7月,查找报告印度HCC病因数据的研究。使用汇总统计计算95%置信区间的合并比例。
最终分析共纳入60项研究(n = 12327)。至少有一项阳性和阴性病毒标志物的HCC病例的合并比例分别为56.0(49.5 - 62.6)和43.1%(36.5 - 49.8)。乙型肝炎病毒(HBV)标志物阳性的HCC病例的合并比例为41.0(35.8 - 46.1),而丙型肝炎病毒标志物阳性的病例为20.3(17.0 - 23.6)。大量饮酒导致HCC的病例合并比例为19.0%(15.6 - 22.4),与非酒精性脂肪性肝病(NAFLD)相关的病例为16.9%(12.1 - 21.7)。约7.9%(5.8 - 10.0)的病例的HCC有多种病因。亚组分析显示,根据地区划分,研究地点存在显著差异。基于发表年份(1990 - 2023)的Meta回归分析显示,HBV病例的比例显著下降,NAFLD病例的比例上升。相比之下,丙型肝炎病毒和酒精相关病例的比例没有显著变化。
病毒性肝炎是印度HCC最常见的病因,主要是HBV。与NAFLD相关的HCC病例比例在增加,而与HBV相关的病例比例在下降。